SFE Investment Counsel’s Elanco Animal Health ELAN Stock Holding History

SFE Investment Counsel’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,720	Closed	-$228K	–	122
2022 Q1	$228K	Sell	8,720 -13,875	-61%	-$370K	0.06%	119
2021 Q4	$641K	Sell	22,595 -125	-0.6%	-$3.89K	0.16%	92
2021 Q3	$725K	Sell	22,720 -250	-1%	-$8.39K	0.2%	92
2021 Q2	$797K	Sell	22,970 -900	-4%	-$29.7K	0.22%	88
2021 Q1	$703K	Buy	23,870 +550	+2%	+$16.9K	0.2%	85
2020 Q4	$715K	Hold	23,320	–	–	0.23%	84
2020 Q3	$651K	Buy	23,320 +420	+2%	+$10.6K	0.26%	80
2020 Q2	$491K	Buy	22,900 +1,300	+6%	+$28.7K	0.22%	79
2020 Q1	$484K	Buy	21,600 +1,250	+6%	+$34.2K	0.27%	79
2019 Q4	$599K	Buy	20,350 +6,420	+46%	+$174K	0.25%	82
2019 Q3	$370K	Buy	+13,930	New	+$418K	0.16%	95

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SFE Investment Counsel's ELAN Position: Q2 2022 in Review

SFE Investment Counsel sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 8,720 shares — an estimated $228K sold.

SFE Investment Counsel first reported a position in ELAN in Q3 2019 and held it in 11 quarters. The position peaked at $797K in Q2 2021. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

SFE Investment Counsel reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
SFE Investment Counsel sold 8,720 Elanco Animal Health shares in Q2 2022, an estimated $228K.
SFE Investment Counsel first reported a position in Elanco Animal Health in Q3 2019 and held it in 11 quarters.
SFE Investment Counsel's Elanco Animal Health position peaked at $797K in Q2 2021.
438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on SFE Investment Counsel's 13F filing for Q2 2022, filed 10 Aug 2022.